Hong Kong
· Delayed Price · Currency is HKD Medlive Technology Statistics
Total Valuation
Medlive Technology has a market cap or net worth of HKD 5.50 billion. The enterprise value is 1.42 billion.
| Market Cap | 5.50B |
| Enterprise Value | 1.42B |
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | Oct 22, 2024 |
Share Statistics
Medlive Technology has 732.85 million shares outstanding. The number of shares has increased by 0.03% in one year.
| Shares Outstanding | 732.85M |
| Shares Change (YoY) | +0.03% |
| Shares Change (QoQ) | +1.01% |
| Owned by Insiders (%) | 1.58% |
| Owned by Institutions (%) | 23.73% |
| Float | 186.19M |
Valuation Ratios
The trailing PE ratio is 17.71 and the forward PE ratio is 18.04.
| PE Ratio | 17.71 |
| Forward PE | 18.04 |
| PS Ratio | 10.54 |
| PB Ratio | 1.09 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 4.55 |
| EV / Sales | 2.74 |
| EV / EBITDA | 12.77 |
| EV / EBIT | 13.31 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 26.91, with a Debt / Equity ratio of 0.34.
| Current Ratio | 26.91 |
| Quick Ratio | 26.64 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | n/a |
| Interest Coverage | 231.37 |
Financial Efficiency
Return on equity (ROE) is 6.46% and return on invested capital (ROIC) is 1.32%.
| Return on Equity (ROE) | 6.46% |
| Return on Assets (ROA) | 1.26% |
| Return on Capital (ROIC) | 1.32% |
| Revenue Per Employee | 694,161 |
| Profits Per Employee | 418,135 |
| Employee Count | 742 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.89% in the last 52 weeks. The beta is 0.63, so Medlive Technology's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +6.89% |
| 50-Day Moving Average | 7.63 |
| 200-Day Moving Average | 7.67 |
| Relative Strength Index (RSI) | 50.53 |
| Average Volume (20 Days) | 635,366 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Medlive Technology had revenue of HKD 517.84 million and earned 311.93 million in profits. Earnings per share was 0.42.
| Revenue | 517.84M |
| Gross Profit | 315.30M |
| Operating Income | 106.65M |
| Pretax Income | 331.61M |
| Net Income | 311.93M |
| EBITDA | 111.10M |
| EBIT | 106.65M |
| Earnings Per Share (EPS) | 0.42 |
Balance Sheet
The company has 4.15 billion in cash and 17.24 million in debt, giving a net cash position of 4.14 billion or 5.64 per share.
| Cash & Cash Equivalents | 4.15B |
| Total Debt | 17.24M |
| Net Cash | 4.14B |
| Net Cash Per Share | 5.64 |
| Equity (Book Value) | 5.08B |
| Book Value Per Share | 6.92 |
| Working Capital | 4.18B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 60.89%, with operating and profit margins of 20.60% and 60.24%.
| Gross Margin | 60.89% |
| Operating Margin | 20.60% |
| Pretax Margin | 64.04% |
| Profit Margin | 60.24% |
| EBITDA Margin | 21.45% |
| EBIT Margin | 20.60% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 3.54%.
| Dividend Per Share | 0.27 |
| Dividend Yield | 3.54% |
| Dividend Growth (YoY) | 240.03% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.03% |
| Shareholder Yield | 3.51% |
| Earnings Yield | 5.65% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |